揭示caudatin的治疗潜力:结构优化,药理机制和治疗影响
Guohui Shi1,2, Linlin Ni3, Xiaoni Kong4
1Medical school, Shandong Xiehe University, Jinan, China.
Frontiers in pharmacology
|September 17, 2025
概括
考达丁是一种来自 *Cynanchum* 的类固醇糖化物,通过调节关键通路,显示出强大的抗癌和抗炎作用. 它作为癌症,炎症和神经退行性疾病的药物支架的潜力是有希望的.
科学领域:
- 自然产品化学 自然产品化学
- 药用化学 医学化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 考达丁是一种C21类固醇糖化物,存在于*Cynanchum*物种中.
- 传统上用于癌症和炎症,由于其药理活动,它是一个潜在的候选药物.
- 本综述侧重于考达丁的结构-活性关系 (SAR),药理学和治疗潜力.
研究的目的:
- 审查caudatin的SAR,药理学和治疗应用.
- 讨论Caudatin作为药物支架的未来挑战和机遇.
- 探索考达丁在治疗癌症,炎症和神经退行性疾病方面的潜力.
主要方法:
- 对考达丁的药理学和SAR的现有文献的审查.
- 分析高达调节的信号通路,包括Wnt/β-catenin,NF-κB和PI3K/AKT.
- 检查神经保护机制和药物动力学概况.
主要成果:
- 考达丁通过诱导亡和抑制上皮细胞-介质细胞转换 (EMT) 来表现出强大的抗癌活性.
- 它通过抑制JNK/AP-1/NF-κB信号传递具有抗炎作用.
- 在阿尔茨海默氏症模型中,通过TFEB激活和PPARα调节观察到神经保护.
- 药物动力学研究表明,在临床前模型中,吸收速度快,肝脏向性和低毒性.
- SAR研究表明,C-3基位置的修改增强了生物活性和可溶性.
结论:
- 考达丁是开发癌症,炎症和神经退行性疾病新疗法的有希望的支架.
- 修改可以优化其治疗潜力,桥梁传统医学和现代药物发现.
- 未来的研究应该专注于合成衍生品,翻译研究和先进配方.
相关概念视频
01:28Structure-Activity Relationships and Drug Design
1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
1.3K
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
1.3K
01:24CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
790
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
790
01:16Calmodulin-dependent Signaling
6.0K
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
6.0K
02:34Inhibition of Cdk Activity
5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
01:26Targets for Drug Action: Overview
10.1K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.1K